Dr. Theodore Rabinovitch and Dr. Vincent Lam are Fellowship trained at the renowned Proctor Eye Foundation, University of California with over twenty five years of combined experience in the treatment of Ocular Inflammatory disease. Their arsenal of medications to reduce ocular inflammation and control uveitis include antibiotics, antivirals, steroids, and steroid sparing agents, like NSAIDs, conventional immunosuppressive agents like: Methotrexate, Leucovorin, CellCept, Cyclosporine, Imuran, Cytoxan and the newer biologic agents like, Rituxin, Remicade, Humira, Orencia, IV-Ig. Complimentary to the use of immunosuppressive agents are the use of intraocular agents Avastin, Lucentis, and sustained release intraocular devises such as Retisert, Ozurdex.
Most cases of uveitis are treated through steroids in the form of eye drops, pills or injections to reduce inflammation in the eye. Retisert may be used to treat chronic posterior uveitis by placing a drug implant in the eye that delivers medication to the eye as needed for over two years. The type and cause of your condition will be used to determine the best treatment option for your individual case.
Dr. Rabinovitch manages the surgical challenges of Uveitis patients including complex cataract extraction.
Click here for clinical trials page »
Ozurdex® is a biodegradable implant containing the corticosteroid dexamethasone. Corticosteroids, such as dexamethasone, block chemical pathways that lead to inflammation, leakage from the retinal blood vessels, and edema (swelling) of the retina. Ozurdex may help reverse some vision loss that may be caused by a retinal vein occlusion (RVO) or by noninfectious uveitis affecting the posterior segment of the eye.